Biomarkers in idiopathic pulmonary fibrosis: Current insight and future direction

Biomarkers in idiopathic pulmonary fibrosis: Current insight and future direction

Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive interstitial lung disease with a dismal prognosis. Early diagnosis, accurate prognosis, and personalized therapeutic interventions are essential for improving patient outcomes. Biomarkers, as measurable indicators of biological process...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Chinese Medical Journal - Pulmonary and Critical Care Medicine 2024-06, Vol.2 (2), p.72-79
Hauptverfasser: Zheng, Zhen, Peng, Fei, Zhou, Yong
Format: Artikel
Sprache:eng
Schlagworte:
Biomarker
Diagnosis
Idiopathic pulmonary fibrosis
Prognosis
Treatment
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 79
container_issue 2
container_start_page 72
container_title Chinese Medical Journal - Pulmonary and Critical Care Medicine
container_volume 2
creator Zheng, Zhen
Peng, Fei
Zhou, Yong
description Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive interstitial lung disease with a dismal prognosis. Early diagnosis, accurate prognosis, and personalized therapeutic interventions are essential for improving patient outcomes. Biomarkers, as measurable indicators of biological processes or disease states, hold significant promise in IPF management. In recent years, there has been a growing interest in identifying and validating biomarkers for IPF, encompassing various molecular, imaging, and clinical approaches. This review provides an in-depth examination of the current landscape of IPF biomarker research, highlighting their potential applications in disease diagnosis, prognosis, and treatment response. Additionally, the challenges and future perspectives of biomarker integration into clinical practice for precision medicine in IPF are discussed.
doi_str_mv 10.1016/j.pccm.2024.04.003
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11221783</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S2772558824000240</els_id><sourcerecordid>3075703369</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2523-2b87d019aec69644fa943ad245c1d153706d2a7a2422feff36fa898858311ba13</originalsourceid><addsrcrecordid>eNp9kVtL7DAUhYMoKuof8EH66MuMubRJKoLo4A0EEfQ5pLk429M2NWkF_70ZxiP6ImzYgXxZ2XsthA4JnhNM-MnrfDCmm1NMyznOhdkG2qVC0FlVSbn547yDDlKCBldY8lIwvo12mKw5JRjvosdLCJ2O_1xMBfQFWAiDHpdgimFqu9Dr-FF4aGJIkE6LxRSj68dMJnhZjoXubeGncYqusBCdGSH0-2jL6za5g6--h56vr54Wt7P7h5u7xcX9zNCKshltpLCY1NoZXvOy9Loumba0rAyxpGICc0u10LSk1DvvGfda1lJWkhHSaML20Plad5iazlmT54q6VUOEvM-HChrU75seluolvCtCKCVCsqxw_KUQw9vk0qg6SMa1re5dmJJiWFQCM8brjNI1arITKTr__Q_BapWHelWrPNQqD4Vz4ZX-0c8Jv5_8dz8DZ2vAZZ_ewUWVDLjeuLWZygb4S_8To-ydXQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3075703369</pqid></control><display><type>article</type><title>Biomarkers in idiopathic pulmonary fibrosis: Current insight and future direction</title><source>PubMed Central Open Access</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Zheng, Zhen ; Peng, Fei ; Zhou, Yong</creator><creatorcontrib>Zheng, Zhen ; Peng, Fei ; Zhou, Yong</creatorcontrib><description>Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive interstitial lung disease with a dismal prognosis. Early diagnosis, accurate prognosis, and personalized therapeutic interventions are essential for improving patient outcomes. Biomarkers, as measurable indicators of biological processes or disease states, hold significant promise in IPF management. In recent years, there has been a growing interest in identifying and validating biomarkers for IPF, encompassing various molecular, imaging, and clinical approaches. This review provides an in-depth examination of the current landscape of IPF biomarker research, highlighting their potential applications in disease diagnosis, prognosis, and treatment response. Additionally, the challenges and future perspectives of biomarker integration into clinical practice for precision medicine in IPF are discussed.</description><identifier>ISSN: 2772-5588</identifier><identifier>EISSN: 2772-5588</identifier><identifier>DOI: 10.1016/j.pccm.2024.04.003</identifier><identifier>PMID: 38962100</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Biomarker ; Diagnosis ; Idiopathic pulmonary fibrosis ; Prognosis ; Treatment</subject><ispartof>Chinese Medical Journal - Pulmonary and Critical Care Medicine, 2024-06, Vol.2 (2), p.72-79</ispartof><rights>2024 The Author(s)</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c2523-2b87d019aec69644fa943ad245c1d153706d2a7a2422feff36fa898858311ba13</cites><orcidid>0000-0003-3131-1912</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11221783/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11221783/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27903,27904,53770,53772</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38962100$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zheng, Zhen</creatorcontrib><creatorcontrib>Peng, Fei</creatorcontrib><creatorcontrib>Zhou, Yong</creatorcontrib><title>Biomarkers in idiopathic pulmonary fibrosis: Current insight and future direction</title><title>Chinese Medical Journal - Pulmonary and Critical Care Medicine</title><addtitle>Chin Med J Pulm Crit Care Med</addtitle><description>Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive interstitial lung disease with a dismal prognosis. Early diagnosis, accurate prognosis, and personalized therapeutic interventions are essential for improving patient outcomes. Biomarkers, as measurable indicators of biological processes or disease states, hold significant promise in IPF management. In recent years, there has been a growing interest in identifying and validating biomarkers for IPF, encompassing various molecular, imaging, and clinical approaches. This review provides an in-depth examination of the current landscape of IPF biomarker research, highlighting their potential applications in disease diagnosis, prognosis, and treatment response. Additionally, the challenges and future perspectives of biomarker integration into clinical practice for precision medicine in IPF are discussed.</description><subject>Biomarker</subject><subject>Diagnosis</subject><subject>Idiopathic pulmonary fibrosis</subject><subject>Prognosis</subject><subject>Treatment</subject><issn>2772-5588</issn><issn>2772-5588</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNp9kVtL7DAUhYMoKuof8EH66MuMubRJKoLo4A0EEfQ5pLk429M2NWkF_70ZxiP6ImzYgXxZ2XsthA4JnhNM-MnrfDCmm1NMyznOhdkG2qVC0FlVSbn547yDDlKCBldY8lIwvo12mKw5JRjvosdLCJ2O_1xMBfQFWAiDHpdgimFqu9Dr-FF4aGJIkE6LxRSj68dMJnhZjoXubeGncYqusBCdGSH0-2jL6za5g6--h56vr54Wt7P7h5u7xcX9zNCKshltpLCY1NoZXvOy9Loumba0rAyxpGICc0u10LSk1DvvGfda1lJWkhHSaML20Plad5iazlmT54q6VUOEvM-HChrU75seluolvCtCKCVCsqxw_KUQw9vk0qg6SMa1re5dmJJiWFQCM8brjNI1arITKTr__Q_BapWHelWrPNQqD4Vz4ZX-0c8Jv5_8dz8DZ2vAZZ_ewUWVDLjeuLWZygb4S_8To-ydXQ</recordid><startdate>202406</startdate><enddate>202406</enddate><creator>Zheng, Zhen</creator><creator>Peng, Fei</creator><creator>Zhou, Yong</creator><general>Elsevier B.V</general><scope>6I.</scope><scope>AAFTH</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-3131-1912</orcidid></search><sort><creationdate>202406</creationdate><title>Biomarkers in idiopathic pulmonary fibrosis: Current insight and future direction</title><author>Zheng, Zhen ; Peng, Fei ; Zhou, Yong</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2523-2b87d019aec69644fa943ad245c1d153706d2a7a2422feff36fa898858311ba13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Biomarker</topic><topic>Diagnosis</topic><topic>Idiopathic pulmonary fibrosis</topic><topic>Prognosis</topic><topic>Treatment</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zheng, Zhen</creatorcontrib><creatorcontrib>Peng, Fei</creatorcontrib><creatorcontrib>Zhou, Yong</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Chinese Medical Journal - Pulmonary and Critical Care Medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zheng, Zhen</au><au>Peng, Fei</au><au>Zhou, Yong</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Biomarkers in idiopathic pulmonary fibrosis: Current insight and future direction</atitle><jtitle>Chinese Medical Journal - Pulmonary and Critical Care Medicine</jtitle><addtitle>Chin Med J Pulm Crit Care Med</addtitle><date>2024-06</date><risdate>2024</risdate><volume>2</volume><issue>2</issue><spage>72</spage><epage>79</epage><pages>72-79</pages><issn>2772-5588</issn><eissn>2772-5588</eissn><abstract>Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive interstitial lung disease with a dismal prognosis. Early diagnosis, accurate prognosis, and personalized therapeutic interventions are essential for improving patient outcomes. Biomarkers, as measurable indicators of biological processes or disease states, hold significant promise in IPF management. In recent years, there has been a growing interest in identifying and validating biomarkers for IPF, encompassing various molecular, imaging, and clinical approaches. This review provides an in-depth examination of the current landscape of IPF biomarker research, highlighting their potential applications in disease diagnosis, prognosis, and treatment response. Additionally, the challenges and future perspectives of biomarker integration into clinical practice for precision medicine in IPF are discussed.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>38962100</pmid><doi>10.1016/j.pccm.2024.04.003</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0003-3131-1912</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2772-5588
ispartof Chinese Medical Journal - Pulmonary and Critical Care Medicine, 2024-06, Vol.2 (2), p.72-79
issn 2772-5588
2772-5588
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11221783
source PubMed Central Open Access; PubMed Central; Alma/SFX Local Collection
subjects Biomarker
Diagnosis
Idiopathic pulmonary fibrosis
Prognosis
Treatment
title Biomarkers in idiopathic pulmonary fibrosis: Current insight and future direction
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T00%3A02%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Biomarkers%20in%20idiopathic%20pulmonary%20fibrosis:%20Current%20insight%20and%20future%20direction&rft.jtitle=Chinese%20Medical%20Journal%20-%20Pulmonary%20and%20Critical%20Care%20Medicine&rft.au=Zheng,%20Zhen&rft.date=2024-06&rft.volume=2&rft.issue=2&rft.spage=72&rft.epage=79&rft.pages=72-79&rft.issn=2772-5588&rft.eissn=2772-5588&rft_id=info:doi/10.1016/j.pccm.2024.04.003&rft_dat=%3Cproquest_pubme%3E3075703369%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3075703369&rft_id=info:pmid/38962100&rft_els_id=S2772558824000240&rfr_iscdi=true